A Multi-center, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Assess the Efficacy, Safety and Tolerability of DFD-04 (itraconazole) Ointment, 5% in Patients with Inflammatory Lesions of Rosacea Over 12-weeks
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 Jul 2017
At a glance
- Drugs Itraconazole (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 20 Jul 2017 Planned End Date changed from 1 Jun 2017 to 1 Sep 2017.
- 05 May 2017 Planned End Date changed from 1 Apr 2017 to 1 Jun 2017.
- 15 Feb 2017 Status changed from recruiting to active, no longer recruiting.